VERA News and Press, Vera Therapeutics Inc. From 12/08/21

Gainers: Inotiv (NASDAQ:NOTV) +13%, Theravance Biopharma (NASDAQ:TBPH) +11%, Biofrontera (NASDAQ:BFRA) +11%, Dare Bioscience (NASDAQ:DARE) +10%, Stereotaxis (NYSE:STXS) +8%. Losers: Radius Health (NASDAQ:RDUS) -43%, Ensysce Biosciences (NASDAQ...

The following slide deck was published by Vera Therapeutics, Inc. in conjunction with this event. For further details see: Vera Therapeutics (VERA) Investor Presentation - Slideshow

SOUTH SAN FRANCISCO, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that Marshall F...

Vera Therapeutics (NASDAQ:VERA): Q3 GAAP EPS of -$0.36. The company reported approximately $86.2 million in cash and cash equivalents as of September 30, 2021. Press Release For further details see: Vera Therapeutics reports Q3 results

Company makes ongoing progress in several areas evaluating atacicept , its lead product candidate Phase 2a JANUS clinical trial showed atacicept administered subcutaneously once weekly demonstrated a durable and substantial reduction in serum galactose-deficient IgA1 ...

Vera Therapeutics (VERA +25.5%) closed higher for the third straight session recording the best intraday performance in over two months to reach the highest level since mid-September. The clinical-stage biotech has more than doubled in value since its IPO in mid-May. However, the shares exper...

Phase 2a JANUS clinical trial showed atacicept administered subcutaneously once weekly demonstrated a durable and substantial reduction in serum galactose-deficient IgA1 (Gd-IgA1) in a dose-dependent manner up to 72 weeks New quartile-based analysis of JANUS results showed ataci...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

SOUTH SAN FRANCISCO, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a clinical-stage biotechnology company focused on developing treatments for immunological diseases that improve patients’ lives, announced today the upcoming presentation of clinica...

Gainers: Xenon Pharmaceuticals XENE +84%. Elmira Savings Bank ESBK +67%. Superior Drilling Products (NYSE:SDPI) +38%. Mexco Energy (NYSE:MXC) +36%. American Resources AREC +33%. Ring Energy (NYSE:REI) +22%. Nine Energy Service (NYSE:NINE) +20%. Progenity (NASDAQ:PROG) +18%. Lio...